Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 5, 2008, Pages

  Park, Sungmi ^a   Bivona, Benjamin J ^a   Feng, Yumei ^a   Lazartigues, Eric ^a   Harrison Bernard, Lisa M ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Hyperglycemia; Juxtamedullary nephron; Radiotelemetry

Indexed keywords

ANGIOTENSIN II; GLUCOSE;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTERIOLE; ARTICLE; AUTOREGULATION; BLOOD STORAGE; BLOOD VESSEL DIAMETER; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; HEART BEAT; HEART RATE; HYPERGLYCEMIA; JUXTAGLOMERULAR APPARATUS; KIDNEY; KIDNEY PERFUSION; LOCOMOTION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; MOUSE STRAIN; NEPHRON; NONHUMAN; PERFUSION; PHENOTYPE; PRIORITY JOURNAL; RENAL ARTERY; SENSORY NERVE; STRAIN DIFFERENCE; TELEMETRY; URINARY EXCRETION; VASOCONSTRICTION;

EID: 57349192865     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90417.2008     Document Type: Article

References (35)

1. Anonymous. National Diabetes Statistics, 2007. Bethesda, MD: National Diabetes Information Clearinghouse, NIDDK, NIH, 2007.
2. Arima S, Ito S, Omata K, Takeuchi K, Abe K. High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles. Kidney Int 48: 683-689, 1995.
3. Bagi Z, Erdei N, Toth A, Li W, Hintze TH, Koller A, Kaley G. Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins. Arterioscler Thromb Vasc Biol 25: 1610-1616, 2005.
4. Bays HE, Bazata DD, Clark NG, Gavin JR III, Green AJ, Lewis SJ, Reed ML, Stewart W, Chapman RH, Fox KM, Grandy S. Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). BMC Public Health 7: 277, 2007.
5. Breyer MD, Bottinger E, Brosius FC III, Coffman TM, Harris RC, Heilig CW, Sharma K. Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005.
6. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495, 1996.
7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287: 356-359, 2002.
8. Gartner K. Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (c57bl/6j db/db and c57bl/ksj db/db). Diabetologia 15: 59-63, 1978.
9. Guo M, Ricardo SD, Deane JA, Shi M, Cullen-McEwen L, Bertram JF. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J Anat 207: 813-821, 2005.
10. 1A receptor null mice. Am J Physiol Renal Physiol 284: F538-F545, 2003.
11. Harrison-Bernard LM, Monjure CJ, Bivona BJ. Efferent arterioles exclusively express the subtype 1A angiotensin receptor: functional insights from genetic mouse models. Am J Physiol Renal Physiol 290: F1177-F1186, 2006.
12. Harrison-Bernard LM, Navar LG. Renal cortical and medullary microvascular blood flow autoregulation in rat. Kidney Int Suppl 57: S23-S29, 1996.
13. Hayashi K, Epstein M, Loutzenhiser R, Forster H. Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J Am Soc Nephrol 2: 1578-1586, 1992.
14. Hayashi K, Kanda T, Homma K, Tokuyama H, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T. Altered renal microvascular response in Zucker obese rats. Metabolism 51: 1553-1561, 2002.
15. Howarth FC, Jacobson M, Shafiullah M, Adeghate E. Long-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats. Exp Physiol 90: 827-835, 2005.
16. Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science 153: 1127-1128, 1966.
17. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14: 439-447, 2000.
18. Lazartigues E, Lawrence AJ, Lamb FS, Davisson RL. Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery. Circ Res 95: 523-531, 2004.
19. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635, 1996.
20. Levine DZ, Iacovitti M, Robertson SJ, Mokhtar GA. Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 290: R975-R981, 2006.
21. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347: 797-805, 2002.
22. Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD, Haynes WG. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens 17: 1949-1953, 1999.
23. Nielsen S, Halliwill JR, Joyner MJ, Jensen MD. Vascular response to angiotensin II in upper body obesity. Hypertension 44: 435-441, 2004.
24. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 2: 397, 1988.
25. Ohishi K, Okwueze MI, Vari RC, Carmines PK. Juxtamedullary microvascular dysfunction during the hyperfiltration stage of diabetes mellitus. Am J Physiol Renal Fluid Electrolyte Physiol 267: F99-F105, 1994.
26. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 84: 3686-3695, 1999.
27. Park S, Bivona BJ, Harrison-Bernard LM. Compromised renal microvascular reactivity of angiotensin type 1 double null mice. Am J Physiol Renal Physiol 293: F60-F67, 2007.
28. Redon J, Lurbe E. Nocturnal blood pressure versus nondipping pattern: what do they mean? Hypertension 51: 41-42, 2008.
29. Schoonmaker GC, Fallet RW, Carmines PK. Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus. Am J Physiol Renal Physiol 278: F302-F309, 2000.
30. Sharma K, McCue P, Dunn S. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284: F1138-F1144, 2003.
31. Stepp DW, Boesen EI, Sullivan JC, Mintz JD, Hair CD, Pollock DM. Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat. Am J Physiol Heart Circ Physiol 293: H2537-H2542, 2007.
32. Takenaka T, Harrison-Bernard LM, Inscho EW, Carmines PK, Navar LG. Autoregulation of afferent arteriolar blood flow in juxtamedullary nephrons. Am J Physiol Renal Fluid Electrolyte Physiol 267: F879-F887, 1994.
33. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48: 58-64, 2006.
34. Walker M III, Harrison-Bernard LM, Cook AK, Navar LG. Dynamic interaction between myogenic and TGF mechanisms in afferent arteriolar blood flow autoregulation. Am J Physiol Renal Physiol 279: F858-F865, 2000.
35. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, Breyer MD, Harris RC. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 17: 2664-2669, 2006.